Work

Costs of home-based respiratory support and oxygen therapy

Year: 2025

Type: article

Abstract: Objective. To assess the direct costs associated with home-based respiratory support and oxygen therapy (RSOT). Material and methods. The study included two stages: prospective follow-up of patients receiving home-based RSOT and economic analysis of results. There were 98 patients (mean age 61 years, 56.9% men) divided into 3 groups depending on home-based RSOT: invasive mechanical ventilation (IMV) — 8 (8.2%), non-invasive ventilation (NIV) — 43 (43.9%) and long-term oxygen therapy (LTOT) — 47 (47.9%). Direct costs of home-based RSOT were estimated. Results. The weighted average monthly expenses per patient with chronic respiratory failure (CRF) requiring RSOT at home were RUR 115.046 (95% CI: RUR 120.374 — 109.717) for IMV, RUR 39.905 (95% CI: RUR 44.336 — RUR 35.473) for NIV and RUR 10.518 (95% CI: RUR 11.128 — RUR 9.909) for LTOT. Most of these costs were related to provision of necessary equipment. Conclusion. Direct costs for home-based RSOT decrease sequentially from IMV to NIV and LTOT.

Source: Medical Technologies Assessment and Choice

DOI: 10.17116/medtech20254703193

Authors: S.N. Avdeev, D.V. Nevzorova, M.V. Avxentyeva, E.S. Larin, A.N. Komarov, I.S. Krysanov, A.O. Bykov, G.S. Nuralieva, B.E. Pervozvanskiy, V.V. Tkachenko, K.A. Krokhin

Institutions: Sechenov University, Scientific Research Institute of Healthcare Organization and Medical Management, Pirogov Russian National Research Medical University

Language: English

Topic: Respiratory Support and Mechanisms

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4414144379

FWCI:

Cites: 11

Cited by:

Related to: 10